Search Results - "Sempoux, C."

Refine Results
  1. 1

    Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population‐based study by Giriens, B., Yan, P., Safroneeva, E., Zwahlen, M., Reinhard, A., Nydegger, A., Vavricka, S., Sempoux, C., Straumann, A., Schoepfer, A. M.

    Published in Allergy (Copenhagen) (01-12-2015)
    “…Background Eosinophilic esophagitis (EoE) is a chronic, inflammatory disease of the esophagus with a rapidly increasing incidence. However, population‐based…”
    Get full text
    Journal Article
  2. 2

    Pancreatic β-cell mass in European subjects with type 2 diabetes by Rahier, J, Guiot, Y, Goebbels, R.M, Sempoux, C, Henquin, J.C

    Published in Diabetes, obesity & metabolism (01-11-2008)
    “…Decreases in both β-cell function and number can contribute to insulin deficiency in type 2 diabetes. Here, we quantified the β-cell mass in pancreas obtained…”
    Get full text
    Journal Article
  3. 3

    Novel Histologic Scoring System for Long‐Term Allograft Fibrosis After Liver Transplantation in Children by Venturi, C., Sempoux, C., Bueno, J., Ferreres Pinas, J. C., Bourdeaux, C., Abarca‐Quinones, J., Rahier, J., Reding, R.

    Published in American journal of transplantation (01-11-2012)
    “…The existing systems for scoring fibrosis were not developed to evaluate transplanted livers. Our aim was to design and validate a novel fibrosis scoring…”
    Get full text
    Journal Article
  4. 4

    Morphological Mosaicism of the Pancreatic Islets: A Novel Anatomopathological Form of Persistent Hyperinsulinemic Hypoglycemia of Infancy by Sempoux, C, Capito, C, Bellanné-Chantelot, C, Verkarre, V, de Lonlay, P, Aigrain, Y, Fekete, C, Guiot, Y, Rahier, J

    “…Background: Morphological studies of the pancreas in persistent hyperinsulinemic hypoglycemia of infancy (PHHI) have focused on the diagnosis of focal vs…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index by Weynand, B., Borbath, I., Bernard, V., Sempoux, C., Gigot, J.-F., Hubert, C., Lannoy, V., Deprez, P. H., Jouret-Mourin, A.

    Published in Cytopathology (Oxford) (01-12-2014)
    “…Objectives Assessment of proliferation by the Ki‐67 labelling index (Ki67‐LI) is an important parameter of pancreatic neuroendocrine tumour (pNET) prognosis on…”
    Get full text
    Journal Article
  7. 7

    Dynamics of Allograft Fibrosis in Pediatric Liver Transplantation by Venturi, C., Sempoux, C., Quinones, J. A., Bourdeaux, C., Hoyos, S. P., Sokal, E., Reding, R.

    Published in American journal of transplantation (01-07-2014)
    “…Progressive liver allograft fibrosis (LAF) is well known to occur long term, as shown by its high prevalence in late posttransplant liver biopsies (LBs). To…”
    Get full text
    Journal Article
  8. 8

    Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology by Borbath, I., Ceratti, A., Verslype, C., Demols, A., Delaunoit, T., Laurent, S., Deleporte, A., Vergauwe, P., Van Maanen, A., Sempoux, C., Van Cutsem, E., Van Laethem, J.L.

    Published in Annals of oncology (01-11-2013)
    “…Cholangiocarcinomas are uncommon tumours with a poor prognosis, that frequently present epidermal growth factor receptor overexpression. In a multi-centre…”
    Get full text
    Journal Article
  9. 9

    Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma by Borbath, I, Verbrugghe, L, Lai, R, Gigot, J.F, Humblet, Y, Piessevaux, H, Sempoux, C

    Published in European journal of cancer (1990) (01-05-2012)
    “…Abstract Background Cholangiocarcinoma (CC) is a rare cancer of the liver. Surgery offers the only chance for cure. When surgery is unfeasible, chemotherapy is…”
    Get full text
    Journal Article
  10. 10
  11. 11

    ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism by Bellanné-Chantelot, C, Saint-Martin, C, Ribeiro, M-J, Vaury, C, Verkarre, V, Arnoux, J-B, Valayannopoulos, V, Gobrecht, S, Sempoux, C, Rahier, J, Fournet, J-C, Jaubert, F, Aigrain, Y, Nihoul-Fékété, C, de Lonlay, P

    Published in Journal of medical genetics (01-11-2010)
    “…Congenital hyperinsulinism (CHI) is characterised by an over secretion of insulin by the pancreatic β-cells. This condition is mostly caused by mutations in…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone by Carrasco, J, Gizzi, M, Pairet, G, Lannoy, V, Lefesvre, P, Gigot, J-F, Hubert, C, Jouret-Mourin, A, Humblet, Y, Canon, J-L, Sempoux, C, Chapaux, X, Danse, E, Tinton, N, Navez, B, Van den Eynde, M

    Published in British journal of cancer (03-11-2015)
    “…Background: Optimal preoperative treatment before colorectal cancer metastases (CRCM) resection remains unclear. This study evaluated pathological responses…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer by Machiels, J-P, Sempoux, C, Scalliet, P, Coche, J-C, Humblet, Y, Van Cutsem, E, Kerger, J, Canon, J-L, Peeters, M, Aydin, S, Laurent, S, Kartheuser, A, Coster, B, Roels, S, Daisne, J-F, Honhon, B, Duck, L, Kirkove, C, Bonny, M-A, Haustermans, K

    Published in Annals of oncology (01-04-2007)
    “…Background: To assess the safety and preliminary efficacy of concurrent radiotherapy, capecitabine, and cetuximab in the preoperative treatment of patients…”
    Get full text
    Journal Article
  16. 16

    The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver by Borbath, I, Leclercq, I, Moulin, P, Sempoux, C, Horsmans, Y

    Published in European journal of cancer (1990) (01-07-2007)
    “…Abstract Hepatocellular carcinoma (HCC) is increasing worldwide and is the fifth main cause of cancer-related death. HCC develops on a preneoplastic organ, the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats by Leclercq, I A, Sempoux, C, Stärkel, P, Horsmans, Y

    Published in Gut (01-07-2006)
    “…Aim: Peroxisome proliferator activated receptor γ (PPARγ) agonists have been shown to prevent hepatic fibrosis in rodents. We evaluated the therapeutic…”
    Get full text
    Journal Article
  19. 19

    Need for objective and reproducible criteria in histopathological assessment of total mesorectal excision specimens: lessons from a national improvement project by Demetter, P., Vandendael, T., Sempoux, C., Ectors, N., Cuvelier, C. A., Nagy, N., Hoorens, A., Jouret-Mourin, A.

    Published in Colorectal disease (01-11-2013)
    “…Aim Data on quality control of the pathologic evaluation of total mesorectal excision (TME) specimens are scarce. We aimed to assess differences between…”
    Get full text
    Journal Article
  20. 20

    Propylthiouracyl-induced severe liver toxicity: An indication for alanine aminotransferase monitoring by Benyounes, M, Sempoux, C, Daumerie, C, Rahier, J, Geubel, A P

    Published in World journal of gastroenterology : WJG (14-10-2006)
    “…Propylthiouracyl (PTU)-related liver toxicity is likely to occur in about 1% of treated patients. In case of acute or subacute hepatitis, liver failure may…”
    Get full text
    Journal Article